Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02433977 · ClinicalTrials.gov registry record · Phase 2
The Effects of NOx and Conjugated Linoleic Acid on Asthmatics
A Phase 2 study of Asthma, sponsored by Gladwin, Mark, MD.
- Completed
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT02433977: Completed Phase 2 study of Asthma, sponsored by Gladwin, Mark, MD.
NCT02433977 is a Phase 2 study of Asthma that has completed, run by Gladwin, Mark, MD. The registered enrollment target is 6 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02433977, a Phase 2 study of Asthma, has completed, sponsored by Gladwin, Mark, MD.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine the hypothesis that in obese asthmatics; treatment with NOx + CLA is well tolerated, safe and will increase eNO while reducing airway oxidative stress. Allied with this, the investigators will define whether supplementing with this bioactive mediator modifies the airway microbiome, and reduces airway inflammation.
Primary Outcome
Determine how CLA and NOx affect airway NO bioavailability (exhaled NO)
Conditions Studied
Interventions
- DRUG Sodium Nitrate
- DIETARY_SUPPLEMENT Conjugated Linolenic Acid
- DRUG Sodium Nitrite
Study Locations (1)
Pennsylvania
- The University of Pittsburgh Asthma Institute at UPMC - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2015-09 |
| Est. Completion | 2019-11 |
| Phase | Phase 2 |
What the finished NCT02433977 record still lists
NCT02433977 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 3 interventions - of which Sodium Nitrate is the first listed.
NCT02433977 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02433977 about?
NCT02433977 is a clinical study titled "The Effects of NOx and Conjugated Linoleic Acid on Asthmatics". This study will examine the hypothesis that in obese asthmatics; treatment with NOx + CLA is well tolerated, safe and will increase eNO while reducing airway oxidative stress. Allied with this, the investigators will define whether supplementing with this bioactive mediator modifies the airway micro...
What is the current status of trial NCT02433977?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2015-09. Estimated completion is 2019-11.
What conditions does trial NCT02433977 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT02433977?
The interventions under investigation include: Sodium Nitrate (DRUG), Conjugated Linolenic Acid (DIETARY_SUPPLEMENT), Sodium Nitrite (DRUG).
Who is sponsoring clinical trial NCT02433977?
This trial is sponsored by Gladwin, Mark, MD, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02433977 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02433977's enrollment target sits among peer trials
6 372nd of 374 higher than 1 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
RECRUITING · Phase 2
-
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
RECRUITING · Phase 2
-
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
RECRUITING · Phase 2
-
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
RECRUITING · Phase 2
-
Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia